Quarterly report [Sections 13 or 15(d)]

Business Combination - Intangible Assets Acquired (Details)

v3.25.3
Business Combination - Intangible Assets Acquired (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Indefinite-Lived Intangible Assets [Roll Forward]    
Impairment $ 0  
Goodwill [Roll Forward]    
Combination Date Fair Value 11,812,476  
Impairment 0  
Carrying Value 12,209,591 $ 12,209,591
Pharmagesic    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   69,500,000
Translation Adj   (1,580,399)
Carrying Value 67,919,601 67,919,601
Goodwill [Roll Forward]    
Combination Date Fair Value   12,493,727
Translation Adj   (284,136)
Carrying Value 12,209,591 12,209,591
Pharmagesic | Halneuron for Cancer Related Pain    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   59,900,000
Translation Adj   (1,362,099)
Carrying Value 58,537,901 58,537,901
Pharmagesic | Halneuron for Chemotherapy Induced Neuropathic Pain    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   9,600,000
Translation Adj   (218,300)
Carrying Value $ 9,381,700 $ 9,381,700